Calidi Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLDI and other ETFs, options, and stocks.About CLDI
Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.
CEOEric E. Poma
CEOEric E. Poma
Employees28
Employees28
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2014
Founded2014
Employees28
Employees28
CLDI Key Statistics
Market cap10.18M
Market cap10.18M
Price-Earnings ratio-0.17
Price-Earnings ratio-0.17
Dividend yield—
Dividend yield—
Average volume70.09K
Average volume70.09K
High today$1.55
High today$1.55
Low today$1.42
Low today$1.42
Open price$1.53
Open price$1.53
Volume74.45K
Volume74.45K
52 Week high$26.04
52 Week high$26.04
52 Week low$1.10
52 Week low$1.10
Stock Snapshot
As of today, Calidi Biotherapeutics(CLDI) shares are valued at $1.48. The company's market cap stands at 10.18M, with a P/E ratio of -0.17.
On 2025-12-08, Calidi Biotherapeutics(CLDI) stock traded between a low of $1.42 and a high of $1.55. Shares are currently priced at $1.48, which is +4.2% above the low and -4.5% below the high.
The Calidi Biotherapeutics(CLDI)'s current trading volume is 74.45K, compared to an average daily volume of 70.09K.
During the past year, Calidi Biotherapeutics(CLDI) stock moved between $1.10 at its lowest and $26.04 at its peak.
During the past year, Calidi Biotherapeutics(CLDI) stock moved between $1.10 at its lowest and $26.04 at its peak.
People also own
Based on the portfolios of people who own CLDI. This list is generated using Robinhood data, and it’s not a recommendation.